CLINICAL TRIALS AT NGMC While clinical trials have recently expanded to include a wide array of specialties, NGMC’s research efforts have historically focused on the areas of oncology and cardiology. Due to the continued hard work and efforts of research nurse managers Donna Patrick, RN, and Trena Davis, RN, as well as our clinical research team, NGMC patients with cancer and heart disease typically have access to more than 40 clinical trials per year.
“Over the last several years, NGMC has seen a strong and steady increase in the number of clinical trials and scholarly activities we’re involved in,” said Dr. Jones. “This includes enhancing patient care with new quality improvement initiatives, evidence-based practice, as well as strong participation in national clinical trials. This dedication to research and advancement truly sets NGMC apart from other healthcare systems in the region and more importantly, it can improve patient care – both now and in the future.”
nghs.com 27
Over the last 15 years, NGMC has participated in several national clinical trials that have brought new therapies to market, including the anticoagulant drug Eliquis, and the breakthrough cancer immunologic drug, Keytruda. NGMC’s participation in the clinical trials helped support the FDA approval of both drugs, which are now considered a standard of care in the respective areas of heart and cancer care.
NGMC IS CURRENTLY OFFERING A WIDE RANGE OF CLINICAL TRIALS. To see if one may be right for you, talk with your doctor to learn more about how you might qualify for a trial. For more information about ongoing research efforts at NGMC, call 770-219-9010 or visit nghs.com/research.
